- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
During the use of Seratinib, active monitoring should be maintained for the following four types of serious adverse reactions. All warning sign...
There are clear contraindications and drug interaction red lines for the use of Seratinib. The following situations are absolutely prohibited o...
During the use of Seratinib, diarrhea, nausea, and fatigue are the most common manageable side effects. The following is a targeted treatment p...
To ensure the efficacy of Ceritinib and reduce the risk of adverse reactions, please strictly follow the following rules for administration and...
During the treatment of gefitinib, it is necessary to closely monitor four serious adverse reactions: differentiation syndrome, QT interval pro...
Gilteritinib poses significant risks in specific patient populations and combination therapy scenarios, and should be strictly avoided or parti...
Nausea, muscle pain (muscle pain), and fatigue are common discomfort reactions during treatment with Girotinib. Taking proactive home managemen...
Gilteritinib is an oral targeted drug used to treat specific types of leukemia. The correct administration method, dosage adjustment, and manag...
During the use of Dotinurad, it is important to pay close attention to the risks related to the kidneys, liver, and joints, and to take prevent...
Some individuals have a significantly increased risk of using Dotinurad due to their own conditions, with severe renal insufficiency being a cl...
